Ception Therapeutics News
Most Popular Ception Therapeutics Story
Cephalon pays $250M to snare Ception Therapeutics
A fresh batch of positive, mid-stage asthma data has persuaded Cephalon to exercise its option to buy Ception Therapeutics for a minimum of $250 million. That payout comes on top of the $100 million... Read more...
Latest Headlines
- February 23, 2010
- November 23, 2009
- January 14, 2009
- January 28, 2008
- August 21, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
